Oxford University this morning announced more promising news in the development of its COVID-19 vaccine. The results from Phase 2 of its AZD122 vaccine trial, published in the Lancet on Thursday, show that the vaccine is as effective for the older demographic as it is for the younger. Story: wfts.tv/3pM5mAe
- Oxford University vaccine results show strong immune response in older demographic ( Download)
- AstraZeneca Covid Vaccine Triggers Strong Immune Response in Elderly: Oxford ( Download)
- Oxford University announces promising COVID clinical trial news l GMA ( Download)
- Coronavirus: Oxford vaccine jab shows positive response in older people | 5 News ( Download)
- Oxford University vaccine results show strong immune response in older demographic ( Download)
- Oxford AstraZeneca Vaccine Effective But Questions Remain for Elderly ( Download)
- AstraZeneca coronavirus vaccine shows promise in elderly ( Download)
- COVID Conversations: Sarah Gilbert on Vaccines ( Download)
- BREAKING: Third COVID vaccine showing positive results ( Download)
- Oxford Vaccine Shows Promise ( Download)
- Oxford's COVID-19 vaccine is highly effective: Phase III trial interim results ( Download)
- UK coronavirus vaccine shows early promise ( Download)
- Oxford study finds COVID-19 vaccine produces immune response ( Download)
- Oxford University Coronavirus Vaccine Safe, Induces Immune Response; What Next ( Download)
- New data reveals Oxford-AstraZeneca vaccine can possibly limit virus transmission ( Download)
